Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________________
Amendment No. 1 to
FORM 10-K
(Mark One)
|
| |
ý | ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
For the fiscal year ended June 30, 2016
|
| |
¨ | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
For the transition period from to
Commission file number: 001-35647
________________________________________________
LIFEVANTAGE CORPORATION
(Exact name of registrant as specified in its charter)
|
| |
Colorado | 90-0224471 |
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) |
| |
9785 S. Monroe, Ste 300 |
Sandy, UT 84070 |
(Address of principal executive offices, including zip code) |
| |
Registrant’s telephone number: (801) 432-9000 |
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $0.001 par value per share
(Title of Class)
________________________________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No ý
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No ý
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý No ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
|
| | | |
Large accelerated filer | ¨ | Accelerated filer | ý |
Non-accelerated filer | ¨ (Do not check if a smaller reporting company) | Smaller reporting company | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No ý
The aggregate market value of the registrant's common stock held by non-affiliates as of December, 31, 2015, the end of the registrant's second fiscal quarter, was approximately $133.2 million, based on a closing market price of $9.52 per share.
The number of shares of common stock (par value $0.001) outstanding as of November 30, 2016, was 14,057,722 shares.
________________________________________________
DOCUMENTS INCORPORATED BY REFERENCE
None.
Explanatory Note
LifeVantage Corporation (the “Company,” “we,” “us,” or “our”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to its annual report on Form 10-K for the fiscal year ended June 30, 2016, which was originally filed on December 12, 2016 (the “Original Filing”). This Amendment is being filed solely to amend the certifications by our Chief Executive Officer (principal executive officer) and our Chief Financial Officer (principal financial officer), which were filed as Exhibits 32.1 and 32.2 to the Original Filing, which inadvertently referenced an incorrect date. The corrected certifications are filed as Exhibits 32.1 and 32.2 to this Amendment. This Amendment does not reflect events occurring after the date of the Original Filing and, other than the re-filing of the referenced certifications, does not modify or update the disclosures in the Original Filing in any way.
PART IV
ITEM 15 — EXHIBITS, FINANCIAL STATEMENT SCHEDULES
The following documents are being filed as part of this report:
Exhibits
See the Exhibit Index following the signature page of this report.
SIGNATURE
Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
| |
LifeVantage Corporation. a Colorado corporation |
| |
By: | /s/ Mark Jaggi |
| Mark Jaggi |
Its: | Chief Financial Officer |
Date: | December 14, 2016 |
EXHIBIT INDEX
|
| | | | |
Exhibit No. | | Document Description | | Filed Herewith or Incorporated by Reference From |
| | | | |
32.1 | | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | | Furnished herewith. |
| | | | |
32.2 | | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | | Furnished herewith. |
| | | | |